 Patricia Heyn
Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Health Equity | 9 | 2025 | 119 | 3.890 |
Why?
| | Cognitive Dysfunction | 9 | 2025 | 451 | 2.760 |
Why?
| | Cerebral Palsy | 6 | 2022 | 127 | 1.880 |
Why?
| | Terminology as Topic | 3 | 2025 | 254 | 1.770 |
Why?
| | Meta-Analysis as Topic | 3 | 2025 | 170 | 1.550 |
Why?
| | Cognition Disorders | 7 | 2016 | 542 | 1.530 |
Why?
| | Exercise | 8 | 2025 | 2196 | 1.280 |
Why?
| | Alzheimer Disease | 6 | 2024 | 614 | 1.230 |
Why?
| | Racism | 4 | 2025 | 149 | 1.150 |
Why?
| | Self-Help Devices | 3 | 2014 | 24 | 1.050 |
Why?
| | Exercise Therapy | 4 | 2025 | 465 | 1.030 |
Why?
| | Activities of Daily Living | 4 | 2021 | 435 | 0.960 |
Why?
| | Physical Therapy Modalities | 2 | 2020 | 328 | 0.880 |
Why?
| | Geriatrics | 5 | 2025 | 95 | 0.870 |
Why?
| | Cognition | 6 | 2025 | 1252 | 0.840 |
Why?
| | Dementia | 6 | 2023 | 296 | 0.810 |
Why?
| | Integrative Medicine | 2 | 2022 | 16 | 0.800 |
Why?
| | Brain-Derived Neurotrophic Factor | 2 | 2021 | 147 | 0.780 |
Why?
| | Video Games | 2 | 2021 | 30 | 0.780 |
Why?
| | Language | 1 | 2026 | 322 | 0.750 |
Why?
| | Social Determinants of Health | 3 | 2024 | 294 | 0.720 |
Why?
| | Parkinson Disease | 3 | 2024 | 595 | 0.720 |
Why?
| | Elder Nutritional Physiological Phenomena | 1 | 2021 | 1 | 0.710 |
Why?
| | Intellectual Disability | 1 | 2023 | 176 | 0.700 |
Why?
| | Artificial Intelligence | 1 | 2026 | 360 | 0.680 |
Why?
| | Humans | 71 | 2026 | 143817 | 0.680 |
Why?
| | Virtual Reality | 1 | 2022 | 75 | 0.680 |
Why?
| | Aging | 5 | 2025 | 1968 | 0.680 |
Why?
| | Nutrition Therapy | 1 | 2021 | 36 | 0.680 |
Why?
| | Complementary Therapies | 2 | 2020 | 94 | 0.660 |
Why?
| | Internet | 1 | 2025 | 699 | 0.640 |
Why?
| | Accidental Falls | 2 | 2021 | 228 | 0.640 |
Why?
| | Developmental Disabilities | 1 | 2023 | 294 | 0.640 |
Why?
| | Brain Injuries, Traumatic | 3 | 2022 | 443 | 0.610 |
Why?
| | Home Care Services | 1 | 2023 | 273 | 0.600 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2019 | 54 | 0.580 |
Why?
| | Review Literature as Topic | 1 | 2019 | 52 | 0.580 |
Why?
| | Dwarfism | 1 | 2018 | 17 | 0.580 |
Why?
| | Polycomb-Group Proteins | 1 | 2018 | 36 | 0.580 |
Why?
| | Gain of Function Mutation | 1 | 2018 | 36 | 0.570 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2018 | 36 | 0.570 |
Why?
| | Editorial Policies | 1 | 2019 | 44 | 0.560 |
Why?
| | Motor Skills | 1 | 2019 | 105 | 0.540 |
Why?
| | Microcephaly | 1 | 2018 | 103 | 0.540 |
Why?
| | Brain Diseases | 1 | 2019 | 152 | 0.540 |
Why?
| | Cell Nucleolus | 1 | 2016 | 20 | 0.510 |
Why?
| | Coiled Bodies | 1 | 2016 | 9 | 0.500 |
Why?
| | Femur Head Necrosis | 1 | 2016 | 15 | 0.490 |
Why?
| | Aged | 19 | 2026 | 25616 | 0.480 |
Why?
| | Hip Dislocation, Congenital | 1 | 2016 | 39 | 0.470 |
Why?
| | Physical and Rehabilitation Medicine | 1 | 2016 | 32 | 0.470 |
Why?
| | Practice Guidelines as Topic | 3 | 2021 | 1525 | 0.450 |
Why?
| | Metabolic Syndrome | 1 | 2019 | 364 | 0.440 |
Why?
| | Blood Pressure | 2 | 2021 | 1751 | 0.440 |
Why?
| | Walking | 2 | 2022 | 560 | 0.440 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2018 | 300 | 0.440 |
Why?
| | Neurodegenerative Diseases | 1 | 2017 | 141 | 0.440 |
Why?
| | Histones | 2 | 2018 | 655 | 0.440 |
Why?
| | Diet | 2 | 2020 | 1266 | 0.430 |
Why?
| | Transcriptional Activation | 1 | 2016 | 382 | 0.430 |
Why?
| | Pain Management | 1 | 2018 | 399 | 0.430 |
Why?
| | Hip Joint | 1 | 2016 | 180 | 0.420 |
Why?
| | Chronic Pain | 1 | 2018 | 283 | 0.400 |
Why?
| | Life Style | 1 | 2016 | 485 | 0.400 |
Why?
| | DNA Methylation | 1 | 2018 | 673 | 0.400 |
Why?
| | Orthopedic Procedures | 1 | 2016 | 233 | 0.400 |
Why?
| | Caregivers | 2 | 2023 | 1025 | 0.380 |
Why?
| | Minority Groups | 2 | 2025 | 280 | 0.370 |
Why?
| | Zebrafish | 1 | 2016 | 524 | 0.360 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2025 | 1688 | 0.360 |
Why?
| | Attitude of Health Personnel | 1 | 2020 | 1174 | 0.360 |
Why?
| | Gene Library | 1 | 2012 | 126 | 0.350 |
Why?
| | Adaptation, Psychological | 1 | 2017 | 705 | 0.350 |
Why?
| | Mobile Applications | 1 | 2014 | 189 | 0.340 |
Why?
| | Brain | 6 | 2024 | 2901 | 0.330 |
Why?
| | Scoliosis | 2 | 2024 | 222 | 0.320 |
Why?
| | Cardiovascular Diseases | 2 | 2019 | 2098 | 0.300 |
Why?
| | Reading | 1 | 2010 | 134 | 0.300 |
Why?
| | Stress, Psychological | 1 | 2017 | 1147 | 0.280 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2012 | 559 | 0.280 |
Why?
| | Mental Health | 3 | 2023 | 774 | 0.270 |
Why?
| | Employment | 1 | 2010 | 180 | 0.270 |
Why?
| | Biomedical Research | 2 | 2025 | 709 | 0.260 |
Why?
| | United States | 9 | 2025 | 15602 | 0.250 |
Why?
| | Physical Endurance | 1 | 2008 | 281 | 0.250 |
Why?
| | Fatigue | 4 | 2023 | 356 | 0.230 |
Why?
| | Resistance Training | 1 | 2008 | 177 | 0.230 |
Why?
| | DNA | 1 | 2012 | 1427 | 0.220 |
Why?
| | Male | 16 | 2025 | 71568 | 0.210 |
Why?
| | Aged, 80 and over | 6 | 2021 | 8130 | 0.210 |
Why?
| | Female | 16 | 2025 | 77569 | 0.200 |
Why?
| | Health Status Disparities | 2 | 2024 | 315 | 0.200 |
Why?
| | Patient Care Team | 2 | 2020 | 676 | 0.200 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2024 | 138 | 0.200 |
Why?
| | Pyruvate Kinase | 1 | 2023 | 27 | 0.200 |
Why?
| | Oral Health | 1 | 2025 | 139 | 0.200 |
Why?
| | Research Personnel | 1 | 2025 | 185 | 0.200 |
Why?
| | Geriatricians | 1 | 2022 | 1 | 0.180 |
Why?
| | Spinal Cord Injuries | 2 | 2017 | 239 | 0.180 |
Why?
| | Acupuncture Therapy | 1 | 2022 | 22 | 0.180 |
Why?
| | Cross-Sectional Studies | 5 | 2025 | 5761 | 0.180 |
Why?
| | Healthcare Disparities | 2 | 2025 | 700 | 0.180 |
Why?
| | Intracranial Pressure | 1 | 2022 | 61 | 0.180 |
Why?
| | Vitamin D Deficiency | 1 | 2024 | 187 | 0.180 |
Why?
| | Risk Assessment | 3 | 2022 | 3556 | 0.170 |
Why?
| | Young Adult | 5 | 2022 | 13914 | 0.170 |
Why?
| | Neuropsychological Tests | 2 | 2021 | 1122 | 0.170 |
Why?
| | Interviews as Topic | 1 | 2024 | 884 | 0.160 |
Why?
| | Hearing Disorders | 1 | 2020 | 10 | 0.160 |
Why?
| | Shoes | 1 | 2020 | 17 | 0.160 |
Why?
| | Hydroxyethylrutoside | 1 | 2019 | 1 | 0.160 |
Why?
| | Rehabilitation Centers | 1 | 2020 | 39 | 0.160 |
Why?
| | Social Participation | 1 | 2020 | 29 | 0.150 |
Why?
| | Climate Change | 1 | 2022 | 195 | 0.150 |
Why?
| | Waist-Hip Ratio | 1 | 2019 | 37 | 0.150 |
Why?
| | Nutritive Value | 1 | 2019 | 38 | 0.150 |
Why?
| | DNA Modification Methylases | 1 | 2018 | 18 | 0.150 |
Why?
| | Cooking | 1 | 2019 | 66 | 0.140 |
Why?
| | Vision Disorders | 1 | 2020 | 175 | 0.140 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2018 | 97 | 0.140 |
Why?
| | Waist Circumference | 1 | 2019 | 141 | 0.140 |
Why?
| | Environment | 1 | 2020 | 306 | 0.140 |
Why?
| | Antifibrinolytic Agents | 1 | 2019 | 61 | 0.140 |
Why?
| | Calcium Channel Blockers | 1 | 2019 | 165 | 0.140 |
Why?
| | Vaccines | 1 | 2022 | 387 | 0.130 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2020 | 258 | 0.130 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2018 | 100 | 0.130 |
Why?
| | Longitudinal Studies | 2 | 2025 | 2947 | 0.130 |
Why?
| | Ribonucleoprotein, U7 Small Nuclear | 1 | 2016 | 2 | 0.130 |
Why?
| | Guidelines as Topic | 1 | 2019 | 270 | 0.130 |
Why?
| | HeLa Cells | 1 | 2018 | 653 | 0.130 |
Why?
| | Ribonucleoproteins, Small Nuclear | 1 | 2016 | 22 | 0.130 |
Why?
| | Risk Factors | 4 | 2023 | 10623 | 0.130 |
Why?
| | Zygote | 1 | 2016 | 14 | 0.130 |
Why?
| | Muscle Strength | 1 | 2020 | 336 | 0.130 |
Why?
| | RNA, Small Nuclear | 1 | 2016 | 38 | 0.130 |
Why?
| | Health Personnel | 1 | 2023 | 741 | 0.130 |
Why?
| | DNA, Ribosomal | 1 | 2016 | 94 | 0.120 |
Why?
| | Brain-Computer Interfaces | 1 | 2016 | 10 | 0.120 |
Why?
| | Spliceosomes | 1 | 2016 | 50 | 0.120 |
Why?
| | Health Promotion | 1 | 2023 | 765 | 0.120 |
Why?
| | Quality of Life | 2 | 2021 | 3141 | 0.120 |
Why?
| | Age Factors | 2 | 2016 | 3288 | 0.120 |
Why?
| | Treatment Outcome | 3 | 2019 | 11459 | 0.120 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2016 | 133 | 0.120 |
Why?
| | Embryonic Development | 1 | 2016 | 126 | 0.120 |
Why?
| | Adolescent | 6 | 2024 | 22233 | 0.120 |
Why?
| | Social Support | 1 | 2020 | 643 | 0.110 |
Why?
| | Pressure Ulcer | 1 | 2015 | 43 | 0.110 |
Why?
| | Pilot Projects | 1 | 2021 | 1851 | 0.110 |
Why?
| | RNA Splicing | 1 | 2016 | 278 | 0.110 |
Why?
| | Adult | 5 | 2022 | 40128 | 0.110 |
Why?
| | Self Report | 1 | 2019 | 864 | 0.100 |
Why?
| | National Institute on Aging (U.S.) | 2 | 2025 | 4 | 0.100 |
Why?
| | Government Programs | 1 | 2014 | 26 | 0.100 |
Why?
| | Sternoclavicular Joint | 1 | 2014 | 12 | 0.100 |
Why?
| | Engineering | 1 | 2014 | 30 | 0.100 |
Why?
| | Surveys and Questionnaires | 3 | 2021 | 6004 | 0.100 |
Why?
| | Anticoagulants | 1 | 2019 | 718 | 0.100 |
Why?
| | Joint Dislocations | 1 | 2014 | 56 | 0.100 |
Why?
| | Odds Ratio | 1 | 2016 | 1057 | 0.100 |
Why?
| | Mice, Transgenic | 1 | 2018 | 2182 | 0.100 |
Why?
| | Brain Mapping | 1 | 2016 | 535 | 0.100 |
Why?
| | Prevalence | 2 | 2019 | 2819 | 0.100 |
Why?
| | Hypertension | 1 | 2021 | 1239 | 0.090 |
Why?
| | Biomarkers | 2 | 2021 | 4248 | 0.090 |
Why?
| | Sleep | 1 | 2020 | 903 | 0.090 |
Why?
| | Protein Binding | 1 | 2018 | 2261 | 0.090 |
Why?
| | Phenotype | 1 | 2021 | 3182 | 0.090 |
Why?
| | Time Factors | 2 | 2016 | 7068 | 0.090 |
Why?
| | Recovery of Function | 1 | 2016 | 695 | 0.090 |
Why?
| | Uracil | 1 | 2012 | 35 | 0.090 |
Why?
| | Clinical Competence | 1 | 2020 | 1226 | 0.090 |
Why?
| | Cells, Cultured | 1 | 2018 | 4172 | 0.080 |
Why?
| | Articulation Disorders | 1 | 2010 | 7 | 0.080 |
Why?
| | Middle Aged | 4 | 2025 | 35629 | 0.080 |
Why?
| | Research | 1 | 2014 | 426 | 0.080 |
Why?
| | Cell Line, Tumor | 1 | 2018 | 3609 | 0.080 |
Why?
| | Models, Biological | 1 | 2016 | 1833 | 0.070 |
Why?
| | DNA Damage | 1 | 2012 | 432 | 0.070 |
Why?
| | Fractures, Bone | 1 | 2014 | 416 | 0.070 |
Why?
| | Comprehension | 1 | 2010 | 181 | 0.070 |
Why?
| | Child Welfare | 1 | 2010 | 229 | 0.070 |
Why?
| | Research Design | 2 | 2024 | 1121 | 0.070 |
Why?
| | Animals | 4 | 2023 | 38140 | 0.070 |
Why?
| | Stroke | 1 | 2017 | 1219 | 0.070 |
Why?
| | Disability Evaluation | 1 | 2010 | 306 | 0.070 |
Why?
| | Neoplasms | 1 | 2023 | 2902 | 0.070 |
Why?
| | Primary Health Care | 1 | 2017 | 1757 | 0.060 |
Why?
| | Severity of Illness Index | 2 | 2017 | 2925 | 0.060 |
Why?
| | Qualitative Research | 2 | 2024 | 1626 | 0.060 |
Why?
| | Mass Screening | 2 | 2022 | 1325 | 0.060 |
Why?
| | Logic | 1 | 2024 | 6 | 0.060 |
Why?
| | Child | 4 | 2024 | 22441 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2024 | 3614 | 0.050 |
Why?
| | India | 1 | 2025 | 216 | 0.050 |
Why?
| | Eye Diseases | 1 | 2005 | 94 | 0.050 |
Why?
| | Academies and Institutes | 1 | 2024 | 61 | 0.050 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2023 | 25 | 0.050 |
Why?
| | Thioredoxins | 1 | 2023 | 32 | 0.050 |
Why?
| | Sampling Studies | 1 | 2003 | 100 | 0.050 |
Why?
| | Rural Health | 1 | 2023 | 86 | 0.050 |
Why?
| | Depressive Disorder | 1 | 2006 | 367 | 0.050 |
Why?
| | Head | 1 | 2024 | 120 | 0.050 |
Why?
| | Braces | 1 | 2022 | 23 | 0.050 |
Why?
| | Walking Speed | 1 | 2022 | 52 | 0.040 |
Why?
| | Nursing Homes | 1 | 2003 | 172 | 0.040 |
Why?
| | Mice | 1 | 2018 | 18421 | 0.040 |
Why?
| | Immunoglobulin A | 1 | 2022 | 218 | 0.040 |
Why?
| | Vision Tests | 1 | 2020 | 22 | 0.040 |
Why?
| | Affect | 1 | 2003 | 318 | 0.040 |
Why?
| | Vitamin D | 1 | 2024 | 402 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2023 | 645 | 0.040 |
Why?
| | Hypnotics and Sedatives | 1 | 2022 | 215 | 0.040 |
Why?
| | Fellowships and Scholarships | 1 | 2024 | 346 | 0.040 |
Why?
| | Homeodomain Proteins | 1 | 2024 | 524 | 0.040 |
Why?
| | Hearing Tests | 1 | 2020 | 49 | 0.040 |
Why?
| | Hearing | 1 | 2021 | 128 | 0.040 |
Why?
| | Gait | 1 | 2022 | 324 | 0.040 |
Why?
| | Infant, Newborn | 1 | 2010 | 6362 | 0.040 |
Why?
| | Health Behavior | 1 | 2004 | 794 | 0.040 |
Why?
| | Rural Population | 1 | 2023 | 638 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2022 | 464 | 0.030 |
Why?
| | Antihypertensive Agents | 1 | 2021 | 500 | 0.030 |
Why?
| | Hypesthesia | 1 | 2017 | 21 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2006 | 1255 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2024 | 1446 | 0.030 |
Why?
| | Executive Function | 1 | 2021 | 455 | 0.030 |
Why?
| | Muscle Weakness | 1 | 2017 | 95 | 0.030 |
Why?
| | Infant | 1 | 2010 | 9886 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2024 | 2167 | 0.030 |
Why?
| | Symptom Assessment | 1 | 2017 | 130 | 0.030 |
Why?
| | Memory Disorders | 1 | 2017 | 195 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2017 | 247 | 0.030 |
Why?
| | Transcription Factors | 1 | 2024 | 1735 | 0.030 |
Why?
| | Child, Preschool | 1 | 2010 | 11631 | 0.030 |
Why?
| | Curriculum | 1 | 2022 | 1044 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2871 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2024 | 2407 | 0.030 |
Why?
| | Risk Reduction Behavior | 1 | 2017 | 228 | 0.030 |
Why?
| | Alcohol Drinking | 1 | 2021 | 831 | 0.030 |
Why?
| | Manipulation, Orthopedic | 1 | 2014 | 8 | 0.030 |
Why?
| | Immobilization | 1 | 2014 | 51 | 0.030 |
Why?
| | Clavicle | 1 | 2014 | 37 | 0.030 |
Why?
| | Emotions | 1 | 2017 | 575 | 0.020 |
Why?
| | Fracture Fixation, Internal | 1 | 2014 | 206 | 0.020 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2005 | 80 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2022 | 16755 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2014 | 2894 | 0.010 |
Why?
| | Logistic Models | 1 | 2005 | 2095 | 0.010 |
Why?
|
|
Heyn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|